Barentzymes AS is a biotechnology company founded in 2013 and has its headquarters in

Tromsø Tromsø (, , ; se, Romsa ; fkv, Tromssa; sv, Tromsö) is a municipality in Troms og Finnmark county, Norway. The administrative centre of the municipality is the city of Tromsø. Tromsø lies in Northern Norway. The municipality is the ...

, Northern Norway.

Structure

The company was established in December 2013 by Jan B. Andersen, former CEO of ArcticZymes AS, together with Sigurd Aase, a private Norwegian investor. Headquarters and a wetlab are located in Tromsø with 9 employees. Bioinformatics and business development with 6 employees are situated in

Copenhagen Copenhagen ( or .; da, København ) is the capital and most populous city of Denmark, with a proper population of around 815.000 in the last quarter of 2022; and some 1.370,000 in the urban area; and the wider Copenhagen metropolitan ar ...

, Denmark. The in silico team have been recruited from the Center for Biological Sequence Analysis, DTU, and The Bioinstitute at Aalborg University, Campus Copenhagen.

Operations

Barentzymes brings to the market new enzymes for industrial biotechnology application, initially with a focus on bio-degradation of biological resources for food and non-food applications. The company was selected for a visit by the

Ministry of Trade and Industry (Norway) The Royal Norwegian Ministry of Trade and Industry ( Norwegian: Nærings- og handelsdepartementet) was a Norwegian ministry responsible for business, trade and industry. On 1 January 2014 it was merged into Ministry of Trade, Industry and Fisheri ...

in recognition of its work in the field of biotechnology. Barentzymes is focused on the development of new original enzymes from the genetic resources of the

Barents Sea The Barents Sea ( , also ; no, Barentshavet, ; russian: Баренцево море, Barentsevo More) is a marginal sea of the Arctic Ocean, located off the northern coasts of Norway and Russia and divided between Norwegian and Russian territo ...

. Barentzymes uses a bioinformatic approach known as Peptide Pattern Recognition principle (PPR) to discover new β-glucosidases from Mucor circinelloides. Barentzymes have in its team experts who have developed a new advanced discovery platform that allows to profile new enzyme’s properties already at the sequence level. This ability to predict properties of an enzyme on an in silico level makes it possible for Barentzymes to reduce time and costs from the moment of the development of an enzyme to the testing of an enzyme for customer’s specific applications. Barentzymes work with specific needs of a customer and produce tailored solutions that solve a customer's particular problem. The company is a part of cluster active in the region of Northern Norway that aims at bringing together public institutions and industry representatives in an effort to research and commercialize the biodiversity of

.{{Cite web, url=http://www.biotechnorth.no/, title=Front Page, website=BioTech North, access-date=2022-02-11, archive-date=2022-02-01, archive-url=https://web.archive.org/web/20220201003706/https://www.biotechnorth.no/, url-status=live

Current status

The funding of the company was stopped on a short notice, and its operations were finished in mid 2015.

References

External links

Barentzymes website
Biotechnology companies established in 2013 Companies based in Tromsø Biotechnology companies of Norway Norwegian brands Norwegian companies established in 2013